Seydel, Joachim Karl published the artcileDevelopment of effective drug combinations for the inhibition of multiply resistant mycobacteria, especially of the Mycobacterium avium complex, Computed Properties of 2215-33-0, the publication is Chemotherapy (Basel, Switzerland) (1992), 38(3), 159-68, database is CAplus and MEDLINE.
Rationally designed combinations of rifampicin (RAMP) and thiacetazone plus isonicotinic acid hydrazide and/or ethambutol are highly effective in the treatment of patients (including HIV-pos.) infected with multiply resistant mycobacteria of the M. avium complex (MAC). Clin. results are very promising. The high efficacy of these combinations is due to the synergistic potentiation of single-drug activities. As soon as rifabutin is marketed, it should replace RAMP in the combination treatment of patients with highly RAMP-resistant MAC bacteria.
Chemotherapy (Basel, Switzerland) published new progress about 2215-33-0. 2215-33-0 belongs to pyridine-derivatives, auxiliary class Pyridine,Amine, name is 2-((2-(Pyridin-2-yl)hydrazono)methyl)pyridine, and the molecular formula is 0, Computed Properties of 2215-33-0.
Referemce:
https://en.wikipedia.org/wiki/Pyridine,
Pyridine | C5H5N – PubChem